BD Appoints Lanesha Minnix as New General Counsel, Driving Innovation and Governance

BD Appoints Lanesha Minnix as General Counsel

Franklin Lakes, N.J. – Becton, Dickinson and Company (BD), a prominent name in global medical technology, has announced the appointment of Lanesha Minnix as its new General Counsel and Executive Vice President, effective March 16, 2026. This strategic move marks a significant step in BD's commitment to robust governance and innovative healthcare solutions.

Minnix comes to BD from Walgreens Boots Alliance, where she served as Executive Vice President and Chief Legal Officer. In that role, she oversaw legal, risk management, and corporate affairs, successfully steering the company through a massive $24 billion take-private transaction, one of the largest deals in the health and retail sectors. Her legal acumen and strategic vision were instrumental in navigating complex regulatory landscapes and corporate governance challenges during that transformative period.

Before her tenure at Walgreens, Minnix held pivotal executive positions at Ecolab and Flowserve, where she played a crucial role in modernizing their legal and compliance functions. Her ability to strengthen governance frameworks while delivering measurable operational results has made her a respected leader in the industry.

Leadership Insights from Tom Polen

Tom Polen, BD's Chairman, CEO, and President, highlighted Minnix’s strategic mindset, emphasizing her capability to drive progress in a dynamic enterprise environment. “Driving durable growth and innovation in healthcare requires leaders who can enable progress across the enterprise,” he stated. “Lanesha brings the strategic mindset, governance strength, and operational discipline to help us reach world-class levels of excellence, move faster, and deliver value for our customers and shareholders.” Under her leadership, BD aims to enhance its innovative approach while maintaining stringent compliance with regulations.

Educational Background

Minnix's educational qualifications further bolster her credentials, holding a Juris Doctor and a Master of Business Administration from the University of Tulsa, alongside a Bachelor of Science in Business Administration from Saint Louis University. This diverse academic background equips her with a unique perspective on both legal and business challenges, making her well-suited for the complexities of the medical technology landscape.

About BD

Becton, Dickinson and Company is recognized as one of the largest pure-play medical technology firms globally, dedicated to advancing health through innovation. The company focuses on a range of areas including medical essentials, connected care, biopharma systems, and interventional procedures. BD employs over 60,000 people worldwide and delivers billions of products aimed at enhancing global healthcare outcomes.

By working closely with healthcare providers, BD develops transformative technologies and solutions that optimize clinical operations. These efforts are directed towards improving patient care and making healthcare more accessible. The company’s commitment to reinforcing healthcare systems with innovative products and services aligns seamlessly with Minnix’s leadership philosophy.

As Lanesha Minnix steps into her new role, the medical community looks forward to her impactful contributions towards enhancing governance and driving BD’s mission forward. Her appointment is seen as a step towards integrating strong legal oversight with innovation in healthcare, setting the stage for BD’s sustained leadership in an evolving medical landscape.

For more information about BD and its initiatives, visit the company’s website or connect with them on social media platforms.